New laser approach aims to save sight in diabetic patients

NCT ID NCT07315802

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new pattern of retinal laser treatment combined with anti-VEGF injections for people with proliferative diabetic retinopathy (PDR), a serious eye condition that can lead to blindness. Researchers plan to enroll 300 adults aged 18–70 with stable diabetes and PDR. The goal is to see if this laser pattern better preserves vision and reduces the need for additional treatments compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
argon laser photocoagulation combined with anti-VEGF injection
What this could lead to
If successful, this could offer a more targeted laser treatment that reduces vision loss and the need for additional procedures in people with advanced diabetic eye disease.
What could go wrong
This is an early-stage study (not yet recruiting) with no phase specified. The new laser pattern may not prove better than standard treatment, and risks include retinal burns or worsening vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHOTOCOAGULATION BURN TO RETINA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eye and ENT Hospital of Fudan University

    Shanghai, Shanghai Municipality, 200030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.